Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRIT Capital Partners Regulatory News (RCP)

Share Price Information for RIT Capital Partners (RCP)

Share Price is delayed by 15 minutes
Get Live Data
2,295.00    -10.00 (-0.43%)
Bid:
2,295.00
Ask:
2,305.00
Spread: 10.00 (0.436%)
Market Cap: £3.11b
RCP Live PriceLast checked at - London Stock Exchange

Intraday RIT Capital Partners Share Chart

Net Asset Value(s)

18 Apr 2024 07:00

RNS Number : 0437L
RIT Capital Partners PLC
18 April 2024
Β 

RIT Capital Partners PLC (LEI: P31Q1NLTW35JJGHA4667)

Β 

18 April 2024

Β 

Β 

31 March 2024 Net Asset Value

Β 

The unaudited diluted net asset value (NAV) of RIT Capital Partners plc as at 31 March 2024 (with debt at fair value) was 2,536p per Β£1 ordinary share (29 February 2024: 2,474p).

Β 

Q1 2024 Commentary

Β 

RIT's NAV per share total return for Q1 2024 was +4.6% and total net assets as at 31 March stood at approximately Β£3.7 billion. Performance was led by strong returns from our Quoted Equities and Uncorrelated Strategies books, while Private Investments held steady.

Β 

Our CPI+3% reference hurdle gained 1.6% during the quarter, while the MSCI ACWI (50% Β£) returned +9.5%. As in 2023, headline market-cap weighted equity indices in Q1 this year were driven primarily by a small number of large capitalisation technology stocks. For comparison, the MSCI ACWI Equal Weighted Index returned +4.3% in Q1.

Β 

RIT runs a flexible and global portfolio, diversified across our three core pillars of Quoted Equities, Private Investments and Uncorrelated Strategies, and supported by disciplined risk management.

Β 

Β·

Quoted Equities (42% of NAV) returned approximately +9% in the quarter. Returns kept pace with equity markets, despite our minimal exposure to technology stocks which drove headline indices.

oΒ 

Performance was driven by strong stock picking in small and mid-cap equities, which returned double digits. Holdings such as Talen Energy, a US power producer, and Vistry, a UK housebuilder, were solid performers in the period.

Β 

oΒ 

The small and mid-cap equities sector has been an active area of focus recently. This reflects our focus on 'overlooked' areas of the market that are trading at attractive prices.

Β 

oΒ 

Our external fund managers also had a solid quarter, led by our Japan-focused specialist partners.

Β 

Β·

Private Investments (35% of NAV) were flat in the quarter. These investments are long-term in nature. Over the last five years to 31 December, the private investments book has returned approximately 20% on an annualised basis.

oΒ 

We continue to focus on liquidity for our private holdings in line with our aim to reduce the share of private investments to approximately 25-30% of the NAV over time.

Β 

oΒ 

During the quarter, we received final cash proceeds from the sale of Infinity. Webull, our second largest direct holding, announced it will go public on the NASDAQ in the second half of 2024.

oΒ 

As of 31 March, 77% of private funds were valued at 31 December reported valuations and 23% were held at 30 September reported valuations. All private direct positions are valued at 31 December, in line with our half-yearly valuation process for these holdings.

Β 

Β·

Uncorrelated Strategies (25% of NAV) returned approximately +3% in the quarter. The portfolio continues to generate healthy absolute returns and is a diversifier in the NAV.

oΒ 

Returns were driven by positive contributions from our credit holdings.

oΒ 

We also saw strong returns from real assets, including gold.

Β·

Currencies had a slight impact during the quarter, contributing approximately -0.2% to the NAV return due to hedging costs we incurred as part of our active currency risk management.

Β 

Β·

Discounts widened across much of the industry during Q1, and RIT was no exception. During the period, the Board continued its robust capital allocation programme.

oΒ 

Since early 2023, we have returned nearly Β£240 million of capital to shareholders, including repurchasing more than Β£180 million of shares. This equates to ~6.2% of total share capital and is one of the largest buyback programmes in the industry.

Β 

oΒ 

During the quarter, we repurchased a further circa 1.1 million shares on behalf of shareholders, which is directly accretive to the NAV per share.

Β 

Β·

The Board has announced a dividend of 39 pence per share for 2024, a 2.6% increase over the prior year and marking the 10th consecutive year of dividend increases. The first interim dividend will be paid on 26 April to shareholders of record as of 5 April 2024. The second interim dividend will be paid in October.

Β 

Β 

Recent geopolitical events, coupled with a complex macro-economic outlook, suggests some caution is warranted. Against this backdrop, our focus is on identifying unique opportunities trading at attractive valuations. In listed equity markets, we are looking in the small and mid-cap space, and in situations with a clear catalyst on the horizon that can help drive value. We are also seeing opportunities in selective areas of liquid credit markets, with the potential to generate double-digit returns via high quality credits, while taking limited risk to our capital. In private investments, several core holdings are actively exploring sales or IPOs. Our approach is to maintain a balanced positioning in the portfolio, with a continued focus on diversification and disciplined risk management.

Β 

Β 

For more information:

J. Rothschild Capital Management (Manager):

T: 020 7647 8565

E: investorrelations@ritcap.co.uk

Β 

Numis (Joint Broker):

David Benda

T: 020 7260 1000

Β 

JP Morgan Cazenove (Joint Broker):

William Simmonds

T: 020 3493 8000

Β 

Brunswick Group LLP (Media enquiries):

Nick Cosgrove, Tom Burns

T:Β 020 7404 5959

E:Β RIT@BrunswickGroup.comΒ 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
NAVDDLFFZZLZBBQ
Date   Source Headline
15th May 20197:00 amRNSNet Asset Value(s)
12th Apr 20197:00 amRNSNet Asset Value(s)
3rd Apr 20193:59 pmRNSQUARTERLY DISCLOSURE - Listing Rule 15.6.8
22nd Mar 20194:01 pmRNSDirector/PDMR Shareholding
14th Mar 20197:00 amRNSNet Asset Value(s)
5th Mar 20197:00 amRNSAnnual Financial Report
18th Feb 20197:00 amRNSNet Asset Value(s)
5th Feb 20197:00 amRNSNet Asset Value(s)
8th Jan 201910:02 amRNSQuarterly Disclosure: Listing Rule 15.6.8
14th Dec 20187:00 amRNSNet Asset Value(s)
30th Nov 201810:53 amRNSComposition of Board Committee
14th Nov 20187:00 amRNSNet Asset Value(s)
29th Oct 20184:59 pmRNSComposition of Board Committee
16th Oct 201811:11 amRNSDirector Declaration
12th Oct 20187:00 amRNSNet Asset Value(s)
5th Oct 20185:03 pmRNSDirector/PDMR Shareholding
4th Oct 20185:46 pmRNSQuarterly Disclosure: Listing Rule 15.6.8
14th Sep 20187:00 amRNSNet Asset Value(s)
24th Aug 20183:15 pmRNSAppointment of Joint Broker
14th Aug 20187:00 amRNSNet Asset Value(s)
7th Aug 20187:00 amRNSHalf-year Report
18th Jul 20187:00 amRNSNet Asset Value(s)
3rd Jul 20186:00 pmRNSQuarterly Disclosure: Listing Rule 15.6.8
14th Jun 20187:00 amRNSNet Asset Value(s)
15th May 20187:00 amRNSNet Asset Value(s)
26th Apr 201812:41 pmRNSDirectorate Change
26th Apr 201812:27 pmRNSResult of AGM
16th Apr 20187:25 amRNSNet Asset Value(s)
6th Apr 20185:54 pmRNSQuarterly Disclosure: Listing Rule 15.6.8
28th Mar 20185:09 pmRNSDirector/PDMR Shareholding
26th Mar 201811:54 amRNSDirectorate Change
14th Mar 20187:00 amRNSNet Asset Value(s)
5th Mar 20186:00 pmRNSDirector/PDMR Shareholding
27th Feb 20187:00 amRNSFinal Results and Dividend
14th Feb 20187:00 amRNSNet Asset Value(s)
5th Feb 201810:02 amRNSInitiation research from QuotedData
31st Jan 20187:00 amRNSNet Asset Value(s)
22nd Dec 201710:08 amRNSDirector/PDMR Shareholding
22nd Dec 20177:00 amRNSDirectorate Change
20th Dec 20174:17 pmRNSDirector Declaration
14th Dec 20177:00 amRNSNet Asset Value(s)
27th Nov 20175:54 pmRNSDirector/PDMR Shareholding
16th Nov 20175:28 pmRNSComposition of Board Committee
14th Nov 20177:00 amRNSNet Asset Value(s)
19th Oct 20174:19 pmRNSDirectorate Change
16th Oct 20177:00 amRNSNet Asset Value(s)
14th Sep 20177:00 amRNSNet Asset Value(s)
14th Aug 20177:00 amRNSNet Asset Value(s)
14th Aug 20177:00 amRNSHalf-year Report
21st Jul 201710:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.